Cargando…
Assessment of proton-pump inhibitor use at a tertiary teaching hospital in Nigeria
BACKGROUND: Proton-pump inhibitor (PPI) is a widely used medication class globally. Because of its good safety profile, there is a huge likelihood of inappropriate use. OBJECTIVES: To determine the prevalence of PPI use and indications, describe its pattern of usage, and identify factors associated...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413602/ https://www.ncbi.nlm.nih.gov/pubmed/36204491 http://dx.doi.org/10.1177/23992026211062729 |
_version_ | 1784775790234173440 |
---|---|
author | Okoro, Roland Nnaemeka Abdullahi, Kasim Dayar, Dauda Ayuba |
author_facet | Okoro, Roland Nnaemeka Abdullahi, Kasim Dayar, Dauda Ayuba |
author_sort | Okoro, Roland Nnaemeka |
collection | PubMed |
description | BACKGROUND: Proton-pump inhibitor (PPI) is a widely used medication class globally. Because of its good safety profile, there is a huge likelihood of inappropriate use. OBJECTIVES: To determine the prevalence of PPI use and indications, describe its pattern of usage, and identify factors associated with inappropriate prescriptions at a federal tertiary teaching hospital in Maiduguri, Nigeria. METHODS: PPI prescriptions were retrospectively assessed in the General Outpatients’ Department (GOPD) and Gastroenterology Unit (GITU) of a teaching hospital. Relevant data for the study were extracted from the patients’ medical records. Chi-square or Fisher’s exact tests where appropriate were used to identify factors associated with inappropriate PPI prescriptions. A p < 0.05 was considered to be significant. RESULTS: PPIs were prescribed to 73.3% (220/300) of patients, while inappropriate prescriptions were noted in 91.4% (201/220) of these patients. Epigastric pain (49.5%) was the most common PPI indication, while omeprazole was the highest prescribed (53.4%). Nearly all inpatients (98.2%), those with epigastric pain (95.7%), and patients who were prescribed intravenous PPIs had more inappropriate PPI prescriptions compared to others. CONCLUSION: This study revealed a high prevalence of PPI use and inappropriate prescriptions at the study hospital. As a result, these findings highlight the importance PPI-based stewardship program at the study hospital. |
format | Online Article Text |
id | pubmed-9413602 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-94136022022-10-05 Assessment of proton-pump inhibitor use at a tertiary teaching hospital in Nigeria Okoro, Roland Nnaemeka Abdullahi, Kasim Dayar, Dauda Ayuba Med Access Point Care Research @ Point of Care BACKGROUND: Proton-pump inhibitor (PPI) is a widely used medication class globally. Because of its good safety profile, there is a huge likelihood of inappropriate use. OBJECTIVES: To determine the prevalence of PPI use and indications, describe its pattern of usage, and identify factors associated with inappropriate prescriptions at a federal tertiary teaching hospital in Maiduguri, Nigeria. METHODS: PPI prescriptions were retrospectively assessed in the General Outpatients’ Department (GOPD) and Gastroenterology Unit (GITU) of a teaching hospital. Relevant data for the study were extracted from the patients’ medical records. Chi-square or Fisher’s exact tests where appropriate were used to identify factors associated with inappropriate PPI prescriptions. A p < 0.05 was considered to be significant. RESULTS: PPIs were prescribed to 73.3% (220/300) of patients, while inappropriate prescriptions were noted in 91.4% (201/220) of these patients. Epigastric pain (49.5%) was the most common PPI indication, while omeprazole was the highest prescribed (53.4%). Nearly all inpatients (98.2%), those with epigastric pain (95.7%), and patients who were prescribed intravenous PPIs had more inappropriate PPI prescriptions compared to others. CONCLUSION: This study revealed a high prevalence of PPI use and inappropriate prescriptions at the study hospital. As a result, these findings highlight the importance PPI-based stewardship program at the study hospital. SAGE Publications 2021-12-05 /pmc/articles/PMC9413602/ /pubmed/36204491 http://dx.doi.org/10.1177/23992026211062729 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Research @ Point of Care Okoro, Roland Nnaemeka Abdullahi, Kasim Dayar, Dauda Ayuba Assessment of proton-pump inhibitor use at a tertiary teaching hospital in Nigeria |
title | Assessment of proton-pump inhibitor use at a tertiary teaching
hospital in Nigeria |
title_full | Assessment of proton-pump inhibitor use at a tertiary teaching
hospital in Nigeria |
title_fullStr | Assessment of proton-pump inhibitor use at a tertiary teaching
hospital in Nigeria |
title_full_unstemmed | Assessment of proton-pump inhibitor use at a tertiary teaching
hospital in Nigeria |
title_short | Assessment of proton-pump inhibitor use at a tertiary teaching
hospital in Nigeria |
title_sort | assessment of proton-pump inhibitor use at a tertiary teaching
hospital in nigeria |
topic | Research @ Point of Care |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9413602/ https://www.ncbi.nlm.nih.gov/pubmed/36204491 http://dx.doi.org/10.1177/23992026211062729 |
work_keys_str_mv | AT okororolandnnaemeka assessmentofprotonpumpinhibitoruseatatertiaryteachinghospitalinnigeria AT abdullahikasim assessmentofprotonpumpinhibitoruseatatertiaryteachinghospitalinnigeria AT dayardaudaayuba assessmentofprotonpumpinhibitoruseatatertiaryteachinghospitalinnigeria |